Integrated production of human insulin and its C-peptide.

The potential for the development of an integrated process for production of human insulin and its C-peptide in Escherichia coli has been investigated. Human proinsulin was produced intracellularly in E. coli fused to two synthetic IgG-binding domains (ZZ) derived from staphylococcal protein A. High expression levels (3 g/l culture) of the gene product, which accumulated as inclusion bodies, was obtained. Solubilization of inclusion bodies by oxidative sulfitolysis and subsequent renaturation was performed directly after cell lysis and pellet wash. IgG affinity chromatography was used for efficient recovery of pure proinsulin fusion protein in a single step. Monomers of the proinsulin fusion protein constituted approximately 70%. A single step conversion of the fusion protein into insulin and C-peptide by trypsin and carboxypeptidase B treatment was achieved by engineering the junction between proinsulin and its affinity handle, ZZ. Characterization of the cleavage products by reversed phase chromatography (RPC) verified that human insulin and C-peptide were generated and that the ZZ affinity handle was resistant to cleavage. Human insulin and C-peptide were recovered with high yields by preparative reversed-phase high performance liquid chromatography (RP-HPLC). The potential use of the presented scheme for large-scale production of recombinant insulin and/or its C-peptide is discussed.

[1]  E. Holmgren,et al.  An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1–3)insulin-like growth factor I , 1992, Journal of protein chemistry.

[2]  J. Shuster,et al.  High level expression of proinsulin in the yeast, Saccharomyces cerevisiae. , 1987, Gene.

[3]  M. Uhlén,et al.  Single–Step Recovery of a Secreted Recombinant Protein by Expanded Bed Adsorption , 1994, Bio/Technology.

[4]  D. Williams,et al.  Cytoplasmic inclusion bodies in Escherichia coli producing biosynthetic human insulin proteins. , 1982, Science.

[5]  M. Uhlén,et al.  Single-step trypsin cleavage of a fusion protein to obtain human insulin and its C peptide. , 1996, European journal of biochemistry.

[6]  S. Shen Multiple joined genes prevent product degradation in Escherichia coli. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Mathias Uhlén,et al.  Facilitated In Vitro Refolding of Human Recombinant Insulin-Like Growth Factor I Using a Solubilizing Fusion Partner , 1991, Bio/Technology.

[8]  M. Uhlén,et al.  Engineering proteins to facilitate bioprocessing. , 1994, Trends in biotechnology.

[9]  S. Josephson,et al.  Secretion of peptides from E. coli: a production system for the pharmaceutical industry , 1988 .

[10]  M. Östling,et al.  Large–Scale Affinity Purification of Human Insulin–Like Growth Factor I from Culture Medium of Escherichia Coli , 1987, Bio/Technology.

[11]  D. Y. Thomas,et al.  Synthesis of human insulin gene. VIII. Construction of expression vectors for fused proinsulin production in Escherichia coli. , 1984, Gene.

[12]  Y. Kang,et al.  Effect of modification of connecting peptide of proinsulin on its export. , 1994, Journal of biotechnology.

[13]  J. Wahren,et al.  Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. , 1993, The Journal of clinical endocrinology and metabolism.

[14]  O. Kuipers,et al.  Expression of porcine pancreatic phospholipase A2. Generation of active enzyme by sequence-specific cleavage of a hybrid protein from Escherichia coli. , 1987, Nucleic acids research.

[15]  M. Uhlén,et al.  Enhanced in vitro refolding of insulin-like growth factor I using a solubilizing fusion partner. , 1994, Biochemistry.

[16]  B Hammarberg,et al.  Stabilization of recombinant proteins from proteolytic degradation in Escherichia coli using a dual affinity fusion strategy , 1991, Biotechnology and applied biochemistry.

[17]  H. Dahl,et al.  A Novel Enzymatic Method for Production of Authentic hGH from an Escherichia Coli produced hGH–Precursor , 1987, Bio/Technology.

[18]  G. Montelione,et al.  High-level production of uniformly 15N-and 13C-enriched fusion proteins in Escherichia coli , 1996 .

[19]  M. Uhlén,et al.  Fusion proteins in biotechnology. , 1992, Current opinion in biotechnology.

[20]  S. Stahl,et al.  Selection for signal sequence mutations that enhance production of secreted human proinsulin by Escherichia coli. , 1988, Gene.

[21]  K. Brew,et al.  Recombinant bovine alpha-lactalbumin obtained by limited proteolysis of a fusion protein expressed at high levels in Escherichia coli. , 1989, The Journal of biological chemistry.

[22]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[23]  D. Steiner,et al.  Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Carl-Gustaf Rosen,et al.  Process Economics of Animal Cell and Bacterial Fermentations: A Case Study Analysis of Tissue Plasminogen Activator , 1993, Bio/Technology.

[25]  L. Isaksson,et al.  Analysis of rpsD mutations in Escherichia coli. I. Comparison of mutants with various alterations in ribosomal protein S4. , 1979, Molecular & general genetics : MGG.

[26]  W. Gilbert,et al.  Cellular location affects protein stability in Escherichia coli. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. Bourne Observation of an Encounter between Birds and Floating Oil , 1968, Nature.

[28]  C. Cooney Separations for biotechnology. , 1990, Trends in biotechnology.

[29]  I. S. Johnson Human insulin from recombinant DNA technology. , 1983, Science.

[30]  I. Holland,et al.  Protein secretion pathways in Escherichia coli , 1994 .

[31]  D. Steiner,et al.  Studies on the conversion of proinsulin to insulin. I. Conversion in vitro with trypsin and carboxypeptidase B. , 1971, The Journal of biological chemistry.

[32]  A. Kondo,et al.  Engineering Proteins to Enhance their Partition Coefficients in Aqueous Two-Phase Systems , 1991, Bio/Technology.

[33]  M. Uhlén,et al.  A synthetic IgG-binding domain based on staphylococcal protein A. , 1987, Protein engineering.